Trial Profile
Non-Interventional Study Of Celsentri In Treatment Experienced Patients Infected With CCR5 Tropic HIV-1.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms CELTROP
- Sponsors Pfizer; ViiV Healthcare
- 07 Jul 2012 Actual patient number changed from 63 to 79 as reported by ClinicalTrials.gov record.
- 18 Jan 2012 Actual patient number changed from 150 to 63 as reported by ClinicalTrials.gov.
- 18 Jan 2012 Actual end date changed from Mar 2010 to Oct 2011 as reported by ClinicalTrials.gov.